Re: Clinical Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease by Subgroup: Results from two Large, Double-Blind, Randomized, Placebo-Controlled, Phase III Studies.

@article{Seftel2015ReCE,
  title={Re: Clinical Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease by Subgroup: Results from two Large, Double-Blind, Randomized, Placebo-Controlled, Phase III Studies.},
  author={Allen D. Seftel},
  journal={The Journal of urology},
  year={2015},
  volume={194 5},
  pages={1365}
}